Rowasa

Product manufactured by Meda Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA019618 None Rectal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Rowasa® (Mesalamine) Rectal Suspension Enema Is Indicated For The Treatment Of Active Mild To Moderate Distal Ulcerative Colitis, Proctosigmoiditis Or Proctitis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mesalamine MESALAMINE ZINC1688

Comments